Found 53 results for Urology

Webinars

Displaying 9 - 9 of 9Displaying 9 - 9 of 9
No results found.

Videos

Displaying 9 - 10 of 10
No results found.

Courses

Displaying 1 - 1 of 1
No results found.

Medshorts

Displaying 21 - 24 of 34
2Min Read

Optilume BPH Catheter System safe and efficacious for use in treating lower urinary tract symptoms in men

A recent study suggests that Optilume BPH Catheter System, a novel drug/device combination is a minimally invasive surgical therapy that is safe and efficacious for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia. The results of this study were published in The Journal of Urology.

The PINNACLE study was a prospective, randomized, double-blind, sham-controlled trial in which 148 men who were 50 years or older, having symptomatic benign prostatic hyperplasia and a prostate size between 20 and 80 g, were enrolled. They were randomized in a 2:1 ratio to receive either Optilume BPH or a sham surgical procedure for a period of 1 year.

Those who were randomized to receive Optilume BPH (n=100) showed a reduction in International Prostate Symptom Score of 11.5±7.8 points after 1 year. Those on the sham surgical procedure (n=48) showed a reduction of 8.0±8.3 points at 3 months. In the Optilume BPH group, the flow rate was significantly improved (up to 125%) post-treatment.

From the above findings, it may be concluded that Optilume BPH provides immediate and sustained improvements in flow rate and obstructive symptoms and is thus, safe and effective for use in treatment of lower urinary tract symptoms in men.

14 Dec 2024

Optilume BPH Catheter System safe and efficacious for use in treating lower urinary tract symptoms in men

A recent study suggests that Optilume BPH Catheter System, a novel drug/device combination is a minimally invasive surgical therapy that is safe and efficacious for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia. The results of this study were published in The Journal of Urology.

The PINNACLE study was a prospective, randomized, double-blind, sham-controlled trial in which 148 men who were 50 years or older, having symptomatic benign prostatic hyperplasia and a prostate size between 20 and 80 g, were enrolled. They were randomized in a 2:1 ratio to receive either Optilume BPH or a sham surgical procedure for a period of 1 year.

Those who were randomized to receive Optilume BPH (n=100) showed a reduction in International Prostate Symptom Score of 11.5±7.8 points after 1 year. Those on the sham surgical procedure (n=48) showed a reduction of 8.0±8.3 points at 3 months. In the Optilume BPH group, the flow rate was significantly improved (up to 125%) post-treatment.

From the above findings, it may be concluded that Optilume BPH provides immediate and sustained improvements in flow rate and obstructive symptoms and is thus, safe and effective for use in treatment of lower urinary tract symptoms in men.

button

Optilume BPH Catheter System safe and efficacious for use in treating lower urinary tract symptoms in men

A recent study suggests that Optilume BPH Catheter System, a novel drug/device combination is a minimally invasive surgical therapy that is safe and efficacious for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia. The results of this study were published in The Journal of Urology.

The PINNACLE study was a prospective, randomized, double-blind, sham-controlled trial in which 148 men who were 50 years or older, having symptomatic benign prostatic hyperplasia and a prostate size between 20 and 80 g, were enrolled. They were randomized in a 2:1 ratio to receive either Optilume BPH or a sham surgical procedure for a period of 1 year.

Those who were randomized to receive Optilume BPH (n=100) showed a reduction in International Prostate Symptom Score of 11.5±7.8 points after 1 year. Those on the sham surgical procedure (n=48) showed a reduction of 8.0±8.3 points at 3 months. In the Optilume BPH group, the flow rate was significantly improved (up to 125%) post-treatment.

From the above findings, it may be concluded that Optilume BPH provides immediate and sustained improvements in flow rate and obstructive symptoms and is thus, safe and effective for use in treatment of lower urinary tract symptoms in men.

14 Dec 2024
button
2Min Read

Roy Adaptation Model improves psychological well-being and postoperative pain intensity in elderly patients with benign prostatic hyperplasia

A recent study found that there was improvement in psychological well-being, enhancement in health-related quality of life (HRQoL), and reduction in postoperative pain intensity due to Roy Adaptation Model (RAM) in older patients with benign prostatic hyperplasia (BPH) undergoing transurethral resection of the prostate (TURP). This study was published in the journal, BMC Urology.

In this study 160 BPH patients scheduled for TURP procedures were randomly assigned to routine care groups or RAM groups (80 patients each). RAM group was administered standard care based on the RAM model, supplemented with interventions. At the preoperative visit (T0), at 30 days (T1), and at 3 months of follow-up (T2), negative emotions were measured using pain intensity by the Visual Analog Scale (VAS), Hospital Anxiety and Depression Scale (HADS), and HRQoL by the 36-Item Short Form Health Survey (SF-36).

It was observed from repeated measures ANOVA that both the routine care and RAM group had significant differences in psychological well-being, postoperative pain intensity, and HRQoL across the three time points. The RAM group revealed significant reduction in depression and anxiety levels, improvements in various HRQoL domains at T1 and T2, and alleviation of postoperative pain intensity when compared to the routine care group.

From the above results, it can be concluded that RAM model may be incorporated into perioperative care for elderly patients undergoing TURP for BPH as it may enhance HRQoL, improve psychological well-being, and reduce postoperative pain intensity.

07 Dec 2024

Roy Adaptation Model improves psychological well-being and postoperative pain intensity in elderly patients with benign prostatic hyperplasia

A recent study found that there was improvement in psychological well-being, enhancement in health-related quality of life (HRQoL), and reduction in postoperative pain intensity due to Roy Adaptation Model (RAM) in older patients with benign prostatic hyperplasia (BPH) undergoing transurethral resection of the prostate (TURP). This study was published in the journal, BMC Urology.

In this study 160 BPH patients scheduled for TURP procedures were randomly assigned to routine care groups or RAM groups (80 patients each). RAM group was administered standard care based on the RAM model, supplemented with interventions. At the preoperative visit (T0), at 30 days (T1), and at 3 months of follow-up (T2), negative emotions were measured using pain intensity by the Visual Analog Scale (VAS), Hospital Anxiety and Depression Scale (HADS), and HRQoL by the 36-Item Short Form Health Survey (SF-36).

It was observed from repeated measures ANOVA that both the routine care and RAM group had significant differences in psychological well-being, postoperative pain intensity, and HRQoL across the three time points. The RAM group revealed significant reduction in depression and anxiety levels, improvements in various HRQoL domains at T1 and T2, and alleviation of postoperative pain intensity when compared to the routine care group.

From the above results, it can be concluded that RAM model may be incorporated into perioperative care for elderly patients undergoing TURP for BPH as it may enhance HRQoL, improve psychological well-being, and reduce postoperative pain intensity.

button

Roy Adaptation Model improves psychological well-being and postoperative pain intensity in elderly patients with benign prostatic hyperplasia

A recent study found that there was improvement in psychological well-being, enhancement in health-related quality of life (HRQoL), and reduction in postoperative pain intensity due to Roy Adaptation Model (RAM) in older patients with benign prostatic hyperplasia (BPH) undergoing transurethral resection of the prostate (TURP). This study was published in the journal, BMC Urology.

In this study 160 BPH patients scheduled for TURP procedures were randomly assigned to routine care groups or RAM groups (80 patients each). RAM group was administered standard care based on the RAM model, supplemented with interventions. At the preoperative visit (T0), at 30 days (T1), and at 3 months of follow-up (T2), negative emotions were measured using pain intensity by the Visual Analog Scale (VAS), Hospital Anxiety and Depression Scale (HADS), and HRQoL by the 36-Item Short Form Health Survey (SF-36).

It was observed from repeated measures ANOVA that both the routine care and RAM group had significant differences in psychological well-being, postoperative pain intensity, and HRQoL across the three time points. The RAM group revealed significant reduction in depression and anxiety levels, improvements in various HRQoL domains at T1 and T2, and alleviation of postoperative pain intensity when compared to the routine care group.

From the above results, it can be concluded that RAM model may be incorporated into perioperative care for elderly patients undergoing TURP for BPH as it may enhance HRQoL, improve psychological well-being, and reduce postoperative pain intensity.

07 Dec 2024
button
2Min Read

Impact of parent-led massage on the sleep electroencephalogram for term-born infants

According to a recent study, parent-led massage can have an impact on the sleep electroencephalogram (EEG) for term-born infants at 4 months. This study was published in the journal, Developmental medicine and child neurology.

This randomized controlled, parallel-group study enrolled 182 infants at birth, who were randomized to intervention (routine parent-led massage; n=84) and control groups (n=98). Griffiths Scales of Child Development, Third Edition was used to assess daytime sleep EEG at 4 and 18 months. Mann-Whitney U test was used to compare the groups for sleep stage, sleep spindles, quantitative EEG (primary analysis) and Griffiths.

It was observed that 179 out of 182 infants (intervention: 83 and control: 96) had a normal sleep EEG. Median (interquartile range) sleep duration was found to be 49.8 minutes. In the intervention and control groups, a complete first sleep cycle was seen in 67 out of 83 (81%) and 72 out of 96 (75%), respectively. Sleep spindle spectral power was found to be greater in the intervention group in main and subgroup analyses. There was no difference in the Griffiths assessments at 4 and 18 months. Massaged infants had higher sleep spindle spectral power, lower interhemispherical coherence, and greater sleep EEG magnitudes.

Based on the above results, it can be concluded that routine massage of infants may be associated with differences in sleep electroencephalogram biomarkers at 4 months, which may result in distinct functional brain changes.

21 Nov 2024

Impact of parent-led massage on the sleep electroencephalogram for term-born infants

According to a recent study, parent-led massage can have an impact on the sleep electroencephalogram (EEG) for term-born infants at 4 months. This study was published in the journal, Developmental medicine and child neurology.

This randomized controlled, parallel-group study enrolled 182 infants at birth, who were randomized to intervention (routine parent-led massage; n=84) and control groups (n=98). Griffiths Scales of Child Development, Third Edition was used to assess daytime sleep EEG at 4 and 18 months. Mann-Whitney U test was used to compare the groups for sleep stage, sleep spindles, quantitative EEG (primary analysis) and Griffiths.

It was observed that 179 out of 182 infants (intervention: 83 and control: 96) had a normal sleep EEG. Median (interquartile range) sleep duration was found to be 49.8 minutes. In the intervention and control groups, a complete first sleep cycle was seen in 67 out of 83 (81%) and 72 out of 96 (75%), respectively. Sleep spindle spectral power was found to be greater in the intervention group in main and subgroup analyses. There was no difference in the Griffiths assessments at 4 and 18 months. Massaged infants had higher sleep spindle spectral power, lower interhemispherical coherence, and greater sleep EEG magnitudes.

Based on the above results, it can be concluded that routine massage of infants may be associated with differences in sleep electroencephalogram biomarkers at 4 months, which may result in distinct functional brain changes.

button

Impact of parent-led massage on the sleep electroencephalogram for term-born infants

According to a recent study, parent-led massage can have an impact on the sleep electroencephalogram (EEG) for term-born infants at 4 months. This study was published in the journal, Developmental medicine and child neurology.

This randomized controlled, parallel-group study enrolled 182 infants at birth, who were randomized to intervention (routine parent-led massage; n=84) and control groups (n=98). Griffiths Scales of Child Development, Third Edition was used to assess daytime sleep EEG at 4 and 18 months. Mann-Whitney U test was used to compare the groups for sleep stage, sleep spindles, quantitative EEG (primary analysis) and Griffiths.

It was observed that 179 out of 182 infants (intervention: 83 and control: 96) had a normal sleep EEG. Median (interquartile range) sleep duration was found to be 49.8 minutes. In the intervention and control groups, a complete first sleep cycle was seen in 67 out of 83 (81%) and 72 out of 96 (75%), respectively. Sleep spindle spectral power was found to be greater in the intervention group in main and subgroup analyses. There was no difference in the Griffiths assessments at 4 and 18 months. Massaged infants had higher sleep spindle spectral power, lower interhemispherical coherence, and greater sleep EEG magnitudes.

Based on the above results, it can be concluded that routine massage of infants may be associated with differences in sleep electroencephalogram biomarkers at 4 months, which may result in distinct functional brain changes.

21 Nov 2024
button
2Min Read

Vitamin C decreases postoperative catheter-related bladder discomfort

A recent study suggests that administration of Vitamin C has a lower incidence of moderate to severe postoperative catheter-related bladder discomfort (CRBD) in patients with bladder tumor. The results of this study were published in the Journal of clinical anesthesia.

In this double-blind, randomized controlled trial, out of the 118 patients who underwent transurethral resection of bladder tumor, 59 were assigned to receive 1 gm of Vitamin C intravenously. The control group (n=59), was administered normal saline after the induction of anesthesia. The primary endpoint of the study included moderate or severe CRBD immediately postoperatively. The secondary endpoints were moderate or severe CRBD, measured at 1, 2, and 6h after the surgery.

While moderate CRBD symptoms included flailing limbs, intense verbal reactions, and attempts to remove the catheter, more severe forms of CRBD were related to patient behavioral responses. The group receiving Vitamin C showed lower incidence of moderate or severe CRBD immediately after surgery compared to the placebo group. The intervention group also showed significantly lower rates of moderate-to-severe CRBD at 1 and 2 hours postoperatively. Additionally, higher patient satisfaction scores were seen in the group receiving Vitamin C.

Based on the above findings, it can be concluded that Vitamin C administration plays a significant role in decreasing postoperative discomfort related to CRBD in patients with bladder tumor.

22 Sep 2024

Vitamin C decreases postoperative catheter-related bladder discomfort

A recent study suggests that administration of Vitamin C has a lower incidence of moderate to severe postoperative catheter-related bladder discomfort (CRBD) in patients with bladder tumor. The results of this study were published in the Journal of clinical anesthesia.

In this double-blind, randomized controlled trial, out of the 118 patients who underwent transurethral resection of bladder tumor, 59 were assigned to receive 1 gm of Vitamin C intravenously. The control group (n=59), was administered normal saline after the induction of anesthesia. The primary endpoint of the study included moderate or severe CRBD immediately postoperatively. The secondary endpoints were moderate or severe CRBD, measured at 1, 2, and 6h after the surgery.

While moderate CRBD symptoms included flailing limbs, intense verbal reactions, and attempts to remove the catheter, more severe forms of CRBD were related to patient behavioral responses. The group receiving Vitamin C showed lower incidence of moderate or severe CRBD immediately after surgery compared to the placebo group. The intervention group also showed significantly lower rates of moderate-to-severe CRBD at 1 and 2 hours postoperatively. Additionally, higher patient satisfaction scores were seen in the group receiving Vitamin C.

Based on the above findings, it can be concluded that Vitamin C administration plays a significant role in decreasing postoperative discomfort related to CRBD in patients with bladder tumor.

button

Vitamin C decreases postoperative catheter-related bladder discomfort

A recent study suggests that administration of Vitamin C has a lower incidence of moderate to severe postoperative catheter-related bladder discomfort (CRBD) in patients with bladder tumor. The results of this study were published in the Journal of clinical anesthesia.

In this double-blind, randomized controlled trial, out of the 118 patients who underwent transurethral resection of bladder tumor, 59 were assigned to receive 1 gm of Vitamin C intravenously. The control group (n=59), was administered normal saline after the induction of anesthesia. The primary endpoint of the study included moderate or severe CRBD immediately postoperatively. The secondary endpoints were moderate or severe CRBD, measured at 1, 2, and 6h after the surgery.

While moderate CRBD symptoms included flailing limbs, intense verbal reactions, and attempts to remove the catheter, more severe forms of CRBD were related to patient behavioral responses. The group receiving Vitamin C showed lower incidence of moderate or severe CRBD immediately after surgery compared to the placebo group. The intervention group also showed significantly lower rates of moderate-to-severe CRBD at 1 and 2 hours postoperatively. Additionally, higher patient satisfaction scores were seen in the group receiving Vitamin C.

Based on the above findings, it can be concluded that Vitamin C administration plays a significant role in decreasing postoperative discomfort related to CRBD in patients with bladder tumor.

22 Sep 2024
button